Assessment of risk factors for developing incident aortic stenosis: The Tromsø Study

European Journal of Epidemiology

Volumn 29, Issue 8, 2014, Pages 567-575

  Eveborn, Gry Wisthus ^a   Schirmer, Henrik ^a,b   Lunde, Per ^a   Heggelund, Geir ^a   Hansen, John Bjarne ^b   Rasmussen, Knut ^b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Calcific aortic valve disease; Degenerative aortic stenosis; Echocardiography; Epidemiology; Risk factor

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN;

ADULT; AORTA STENOSIS; ARTICLE; COHORT ANALYSIS; DISEASE COURSE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; RISK ASSESSMENT; SMOKING; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

AGED; AORTIC VALVE; AORTIC VALVE STENOSIS; BLOOD PRESSURE; BODY MASS INDEX; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NORWAY; OBESITY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SMOKING; WAIST CIRCUMFERENCE;

EID: 84907934484     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-014-9936-x     Document Type: Article

References (30)

1. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation. 2005;111(24):3316-26. (Pubitemid 40875006)
2. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005-11. (Pubitemid 44353666)
3. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. cardiovascular health study. J Am Coll Cardiol. 1997;29(3):630-4. (Pubitemid 27116107)
4. Lindroos M, Kupari M, Heikkila J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993;21(5):1220-5. (Pubitemid 23106200)
5. Eveborn GW, Schirmer H, Heggelund G, Lunde P, Rasmussen K. The evolving epidemiology of valvular aortic stenosis. The Tromso study. Heart. 2012;. doi:10.1136/heartjnl-2012-302265.
6. Kurtz CE, Otto CM. Aortic stenosis: clinical aspects of diagnosis and management, with 10 illustrative case reports from a 25-year experience. Medicine. 2010;89(6):349-79. doi:10.1097/MD.0b013e3181fe5648.
7. Chan KL. Is aortic stenosis a preventable disease? J Am Coll Cardiol. 2003;42(4):593-9.
8. Jacobsen BK, Eggen AE, Mathiesen EB, Wilsgaard T, Njolstad I. Cohort profile: the Tromso study. Int J Epidemiol. 2011;. doi:10.1093/ije/dyr049.
9. Ix JH, Shlipak MG, Katz R, et al. Kidney function and aortic valve and mitral annular calcification in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis. 2007;50(3):412-20. doi:10.1053/j.ajkd.2007.05.020. (Pubitemid 47285449)
10. Katz R, Wong ND, Kronmal R, et al. Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the multi-ethnic study of atherosclerosis. Circulation. 2006;113(17):2113-9.
11. Stritzke J, Linsel-Nitschke P, Markus MR, et al. Association between degenerative aortic valve disease and long-term exposure to cardiovascular risk factors: results of the longitudinal population-based KORA/MONICA survey. Eur Heart J. 2009;30(16):2044-53. doi:10.1093/eurheartj/ehp287.
12. Perkovic V, Hunt D, Griffin SV, du Plessis M, Becker GJ. Accelerated progression of calcific aortic stenosis in dialysis patients. Nephron Clin Prac. 2003;94(2):c40-5. doi:10.1159/000071280.
13. Bahler RC, Desser DR, Finkelhor RS, Brener SJ, Youssefi M. Factors leading to progression of valvular aortic stenosis. Am J Cardiol. 1999;84(9):1044-8. (Pubitemid 29505373)
14. Palta S, Pai AM, Gill KS, Pai RG. New insights into the progression of aortic stenosis: implications for secondary prevention. Circulation. 2000;101(21):2497-502. (Pubitemid 30366254)
15. Rosenhek R, Binder T, Porenta G, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med. 2000;343(9):611-7. doi:10.1056/nejm200008313430903. (Pubitemid 30659472)
16. Nassimiha D, Aronow WS, Ahn C, Goldman ME. Association of coronary risk factors with progression of valvular aortic stenosis in older persons. Am J Cardiol. 2001;87(11):1313-4. (Pubitemid 32493881)
17. Yamamoto K, Yamamoto H, Yoshida K, et al. Prognostic factors for progression of early- and late-stage calcific aortic valve disease in Japanese: the Japanese Aortic Stenosis Study (JASS) Retrospective Analysis. Hypertens Res. 2010;33(3):269-74. doi:10.1038/hr.2009.225.
18. Rossebo AB, Pedersen TR, Boman K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008;359(13):1343- 56.
19. Cowell SJ, Newby DE, Prescott RJ, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med. 2005;352(23):2389-97. doi:10.1056/NEJMoa043876. (Pubitemid 40958435)
20. Rosenhek R, Rader F, Loho N, et al. Statins but not angiotensin- converting enzyme inhibitors delay progression of aortic stenosis.Circulation. 2004;110(10):1291-5. doi:10.1161/01.CIR.0000140723.15274.53. (Pubitemid 39202347)
21. Antonini-Canterin F, Hirsu M, Popescu BA, et al. Stage-related effect of statin treatment on the progression of aortic valve sclerosis and stenosis. Am J Cardiol. 2008;102(6):738-42. doi:10.1016/j.amjcard.2008.04.056.
22. Kamstrup PR, Tybjaerg-Hansen A, Nordestgaard BG. Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population. J Am Coll Cardiol. 2014;63(5):470-7. doi:10.1016/j.jacc.2013.09.038.
23. Thanassoulis G, Campbell CY, Owens DS, et al. Genetic associations with valvular calcification and aortic stenosis. N Engl J Med. 2013;368(6):503-12. doi:10.1056/NEJMoa1109034.
24. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation. 1994;90(2):844-53. (Pubitemid 24242754)
25. Hermans H, Herijgers P, Holvoet P, et al. Statins for calcific aortic valve stenosis: into oblivion after SALTIRE and SEAS? An extensive review from bench to bedside. Curre Probl Cardiol. 2010;35(6):284-306. doi:10.1016/j. cpcardiol.2010.02.002.
26. Otto CM, Burwash IG, Legget ME, et al. Prospective study of asymptomatic valvular aortic stenosis. clinical, echocardiographic, and exercise predictors of outcome. Circulation. 1997;95(9):2262-70. (Pubitemid 27191003)
27. Yetkin E, Waltenberger J. Molecular and cellular mechanisms of aortic stenosis. Int J Cardiol. 2009;135(1):4-13. doi:10.1016/j.ijcard.2009.03.108.
28. Ortlepp JR, Hoffmann R, Ohme F, Lauscher J, Bleckmann F, Hanrath P. The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart. 2001;85(6):635-8. (Pubitemid 32973456)
29. Dweck MR, Khaw HJ, Sng GK, et al. Aortic stenosis, atherosclerosis, and skeletal bone: is there a common link with calcification and inflammation? Eur Heart J. 2013;34(21):1567-74. doi:10.1093/eurheartj/eht034.
30. Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation. 2005;111(7):920-5. doi:10.1161/01.cir.0000155623.48408.c5. (Pubitemid 40279895)